H STEWART PARKER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for H STEWART PARKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of H STEWART PARKER. H STEWART PARKER is Director in Armata Pharmaceuticals, Inc. ($APHB) and President & CEO in AmpliPhi Biosciences Corp ($APHB) and Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Director in SANGAMO BIOSCIENCES INC ($SGMO) and Director in IMPEL NEUROPHARMA INC ($IMPL).
Latest Insider Trading Transactions of H STEWART PARKER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHV, APHB, IMPL, SGMO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | C | 0.00 | 143,986 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 47,236 | 0 | 143,986 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 47,263 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | C | 0.00 | 120,447 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 13,756 | 0 | 120,447 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 13,756 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | C | 0.00 | 61,109 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Buy | C | 13.50 | 271 | 3,659 | 18,027 | 17.8 K to 18 K (+1.53 %) |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Sell | J | 0.00 | 1,666 | 0 | 17,756 | 19.4 K to 17.8 K (-8.58 %) |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Buy | C | 0.00 | 8,793 | 0 | 19,422 | 10.6 K to 19.4 K (+82.73 %) |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Sell | J | 0.00 | 458 | 0 | 10,629 | 11.1 K to 10.6 K (-4.13 %) |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Buy | C | 0.00 | 7,355 | 0 | 11,087 | 3.7 K to 11.1 K (+197.08 %) |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Buy | C | 0.00 | 3,732 | 0 | 3,732 | 0 to 3.7 K |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 8,200 | 0 | 31,200 | 23 K to 31.2 K (+35.65 %) |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 2,500 | 0 | 15,500 | 13 K to 15.5 K (+19.23 %) |
| May 14 2020 | ACHV | ACHIEVE LIFE SCIEN ... | PARKER H STEWART | Director | Option Exercise | A | 0.43 | 22,000 | 9,460 | 22,000 | |
| Mar 19 2020 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Buy | P | 5.20 | 3,000 | 15,585 | 13,000 | 10 K to 13 K (+30.00 %) |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
| Jun 12 2019 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| May 24 2019 | APHB | Armata Pharmaceuti ... | PARKER H STEWART | Director | Option Exercise | A | 3.15 | 27,383 | 86,256 | 27,383 | |
| Nov 15 2018 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Buy | P | 9.00 | 2,000 | 18,002 | 7,500 | 5.5 K to 7.5 K (+36.36 %) |
| Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | PARKER H STEWART | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
| Sep 07 2018 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Buy | P | 13.52 | 2,000 | 27,040 | 5,500 | 3.5 K to 5.5 K (+57.14 %) |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 15.65 | 15,000 | 234,750 | 15,000 | |
| Jun 12 2018 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Grant | A | 0.00 | 2,500 | 0 | 3,500 | 1,000 to 3.5 K (+250.00 %) |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | PARKER H STEWART | Director | Option Exercise | A | 4.57 | 11,000 | 50,270 | 11,000 | |
| Jun 07 2017 | SGMO | SANGAMO THERAPEUTI ... | PARKER H STEWART | Director | Option Exercise | A | 7.20 | 10,000 | 72,000 | 10,000 | |
| Jun 15 2016 | SGMO | SANGAMO BIOSCIENCE ... | PARKER H STEWART | Director | Option Exercise | A | 5.99 | 10,000 | 59,900 | 10,000 | |
| May 27 2016 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 1.00 | 22,500 | 22,500 | 22,500 | |
| May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| May 24 2016 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Buy | M | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Jun 24 2015 | SGMO | SANGAMO BIOSCIENCE ... | PARKER H STEWART | Director | Option Exercise | A | 11.44 | 10,000 | 114,400 | 10,000 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | A | 1.89 | 5,000 | 9,450 | 5,000 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| May 22 2015 | OGXI | ONCOGENEX PHARMACE ... | PARKER H STEWART | Director | Buy | M | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| May 19 2008 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Grant | A | 0.00 | 50,000 | 0 | 131,175 | 81.2 K to 131.2 K (+61.60 %) |
| May 21 2007 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Grant | A | 0.00 | 50,000 | 0 | 81,175 | 31.2 K to 81.2 K (+160.38 %) |
| Sep 05 2006 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Buy | P | 2.00 | 8,440 | 16,880 | 31,175 | 22.7 K to 31.2 K (+37.12 %) |
| Sep 05 2006 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Buy | P | 1.99 | 200 | 398 | 22,735 | 22.5 K to 22.7 K (+0.89 %) |
| Sep 05 2006 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Buy | P | 1.95 | 1,300 | 2,535 | 22,535 | 21.2 K to 22.5 K (+6.12 %) |
| Sep 05 2006 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Buy | P | 1.91 | 60 | 115 | 21,235 | 21.2 K to 21.2 K (+0.28 %) |
| Jun 13 2006 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Option Exercise | A | 3.80 | 38,000 | 144,400 | 38,000 | |
| May 26 2005 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Option Exercise | A | 0.91 | 100,000 | 91,000 | 100,000 | |
| May 24 2004 | APHB | AmpliPhi Bioscienc ... | PARKER H STEWART | President & CEO | Option Exercise | A | 1.31 | 200,000 | 262,000 | 200,000 |
Page: 1